Clinical Trial

Recurrent Visceral Leishmaniasis in HIV Co-Infection

Study acronym: ALIVE
Recruiting
View on ClinicalTrials.gov →
Summary
The aim is (1) to better understand the underlying causes and predispositions for relapse and parasite persistence in visceral leishmaniasis (VL) patients living with HIV and (2) to improve treatment monitoring of this target group in Ethiopia
Trial Details
NCT Number NCT07487350
Lead Sponsor Institute of Tropical Medicine, Belgium
Collaborators: Armauer Hansen Research Institute, Ethiopia, University of Gondar
Conditions Hiv, Visceral Leishmaniasis
Enrollment 20 participants
Start Date 2025-10-21
Primary Completion 2027-04 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2026-03-23